Trial: 202004253

AN OPEN-LABEL, MULTI-CENTRE, PHASE Ib/II STUDY EVALUATING THE SAFETY AND EFFICACY OF AUTO1, A CAR T CELL TREATMENT TARGETING CD19, IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKAEMIA

Phase

I/II

Principal Investigator

Ghobadi, Armin

Disease Site

Acute Lymphocytic Leukemia (ALL); Lymphoid Leukemia

Learn more about this study at: clinicaltrials.gov